Nationwide Children's Hospital

Running trials

• Not yet recruiting

  VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

  NCT06303687· Nationwide Children's Hospital· Source

• Not yet recruiting

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· Phase 3· Nationwide Children's Hospital· Source

• Not yet recruiting

  Bilevel Positive Airway Pressure (BPAP) for Severe Asthma

  NCT07582211· Columbia University· Source

• Not yet recruiting

  Symptom Trajectory Approaches to Research

  NCT07804875· University of Wisconsin, Madison· Source

• Not yet recruiting

  Nutrition Supplement for Cystic Fibrosis

  NCT07163078· Ohio State University· Source

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

• Not yet recruiting

  Rethinking Early Airway Clearence Therapies

  NCT07696338· Nicole Hamblett· Source

• Recruiting

  Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  NCT07680439· Phase 2· BrainChild Bio, Inc· Source

• Recruiting

  Atomoxetine in Melanocortin Obesity Syndrome

  NCT06899178· Phase 2· Icahn School of Medicine at Mount Sinai· Source

• Enrolling by invitation

  Heart2Heart for Teens With CHD

  NCT07764510· Kristen Fox· Source

• Recruiting

  Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  NCT07725380· Phase 1/2· H. Lee Moffitt Cancer Center and Research Institute· Source

• Recruiting

  The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

  NCT07092540· University of Rochester· Source

• Recruiting

  A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07192952· Phase 3· Bayer· Source

• Recruiting

  The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

  NCT07718204· Nationwide Children's Hospital· Source

• Recruiting

  Phase 2 Study to Assess the Safety and Efficacy of ANG003

  NCT07450547· Phase 2· Anagram Therapeutics, Inc.· Source

• Not yet recruiting

  Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML

  NCT07026942· Phase 1/2· Nationwide Children's Hospital· Source

• Recruiting

  Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

  NCT07312734· Chris Goss· Source

• Recruiting

  Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  NCT07194044· Phase 1· H. Lee Moffitt Cancer Center and Research Institute· Source

• Recruiting

  Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

  NCT07114718· Starlight Cardiovascular Inc· Source

• Active, not recruiting

  Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

  NCT07287189· Phase 2· Satellos Bioscience, Inc.· Source

• Recruiting

  A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

  NCT07227857· Phase 1/2· Institut de Recherches Internationales Servier· Source

• Recruiting

  A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07188805· Phase 3· Bayer· Source

• Enrolling by invitation

  Little NIRVANA for Pediatric Pain and Anxiety

  NCT06795126· Nationwide Children's Hospital· Source

• Recruiting

  Transauricular Neurostimulation for Abdominal Pain Due to DGBI

  NCT07798180· Nationwide Children's Hospital· Source

• Not yet recruiting

  Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

  NCT05779930· Early phase 1· Nationwide Children's Hospital· Source

• Recruiting

  Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease

  NCT06952933· Dartmouth-Hitchcock Medical Center· Source

• Enrolling by invitation

  An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

  NCT06867107· Phase 2· Satellos Bioscience, Inc.· Source

• Recruiting

  Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  NCT06333899· Early phase 1· Nationwide Children's Hospital· Source

• Recruiting

  Re-Engaging AYA Survivors in Cancer-Related Healthcare

  NCT07138040· Children's Hospital of Philadelphia· Source

• Recruiting

  Survivors Journey+

  NCT07321353· Children's Hospital Medical Center, Cincinnati· Source

• Recruiting

  ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  NCT06838676· Phase 2· Nationwide Children's Hospital· Source

• Active, not recruiting

  A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

  NCT06872125· Phase 3· Stoke Therapeutics, Inc· Source

• Recruiting

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT06124157· Phase 2· National Cancer Institute (NCI)· Source

• Recruiting

  Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

  NCT06647953· Phase 3· Children's Oncology Group· Source

• Recruiting

  Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

  NCT04254419· Phase 1· Nationwide Children's Hospital· Source

• Recruiting

  Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

  NCT06513962· Phase 3· Children's Oncology Group· Source

• Recruiting

  Study of Olutasidenib and Temozolomide in HGG

  NCT06161974· Phase 2· Rigel Pharmaceuticals· Source

• Recruiting

  GpCRC Pediatric Gastroparesis Registry 2

  NCT05981300· Johns Hopkins Bloomberg School of Public Health· Source

• Recruiting

  Screen Smart: Using Digital Health to Improve HIV Screening and Prevention

  NCT06003192· Children's Hospital Medical Center, Cincinnati· Source

• Recruiting

  NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  NCT06450041· Phase 2· New Approaches to Neuroblastoma Therapy Consortium· Source

• Recruiting

  A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  NCT06672549· Phase 3· Eli Lilly and Company· Source

• Recruiting

  WBV and Serial Casting for Children With Cerebral Palsy

  NCT06693388· Ben Reader· Source

• Recruiting

  A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

  NCT06368817· Phase 2· Children's Oncology Group· Source

• Recruiting

  Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

  NCT06224660· Phase 1· Sardocor Corp.· Source

• Recruiting

  DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  NCT06525259· George Washington University· Source

• Recruiting

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Nicole Hamblett· Source

• Recruiting

  A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

  NCT06379789· Phase 1/2· Regeneron Pharmaceuticals· Source

• Recruiting

  Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  NCT05843253· Phase 2· Nationwide Children's Hospital· Source

• Recruiting

  Targeted Pediatric High-Grade Glioma Therapy

  NCT05839379· Nationwide Children's Hospital· Source

• Recruiting

  PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  NCT05096481· Phase 2· Nationwide Children's Hospital· Source

Showing 50 of 234.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers64 recruiting
• Acute lymphoblastic leukaemia12 recruiting
• Congenital heart disease11 recruiting
• Cystic fibrosis11 recruiting
• Duchenne muscular dystrophy8 recruiting
• Acute myeloid leukaemia7 recruiting
• Sarcoma7 recruiting
• Neuroblastoma5 recruiting
• Sickle cell disease5 recruiting
• Chronic lymphocytic leukaemia4 recruiting
• Glioblastoma4 recruiting
• Charcot-Marie-Tooth disease3 recruiting
• Down syndrome3 recruiting
• Haemophilia3 recruiting
• Kidney cancer3 recruiting
• Obesity3 recruiting
• Ovarian cancer3 recruiting
• Autism2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Epilepsy2 recruiting
• Gastroparesis2 recruiting
• Heart failure2 recruiting
• Hodgkin lymphoma2 recruiting
• Thalassaemia2 recruiting
• Aortic stenosis1 recruiting
• Aplastic anaemia1 recruiting
• Asthma1 recruiting
• Bladder cancer1 recruiting
• Cerebral palsy1 recruiting
• Crohn's disease1 recruiting
• Cytomegalovirus infection1 recruiting
• Depression1 recruiting
• Dilated cardiomyopathy1 recruiting
• Fabry disease1 recruiting
• Gaucher disease1 recruiting
• Hearing loss1 recruiting
• HIV1 recruiting
• Hydrocephalus1 recruiting
• IgA nephropathy1 recruiting
• Insomnia1 recruiting
• Irritable bowel syndrome1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Lupus (SLE)1 recruiting
• Meningioma1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting
• Peripheral artery disease1 recruiting
• Pompe disease1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Rheumatoid arthritis1 recruiting
• Sjögren's disease1 recruiting
• Spinal muscular atrophy1 recruiting
• Thyroid cancer1 recruiting
• Tuberculosis1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Withdrawn

  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A

  NCT03520751· Phase 1/2· Nationwide Children's Hospital· Source

• Completed

  Mobile Health Program for Teens With Congenital Heart Disease

  NCT07063654· Kristen Fox· Source

• Withdrawn

  A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

  NCT06019481· Regeneron Pharmaceuticals· Source

• Terminated

  A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74

  NCT06597656· Phase 1· Sarepta Therapeutics, Inc.· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Clarametyx Biosciences, Inc.· Source

• Completed

  A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

  NCT06016088· Phase 1/2· Respirion Pharmaceuticals Pty Ltd· Source

• Withdrawn

  Study of a Gene Therapy Treatment for Hemophilia A

  NCT06297486· Phase 3· Spark Therapeutics, Inc.· Source

• Completed

  Phase 1 Study to Assess Safety and Efficacy of ANG003

  NCT06052293· Phase 1· Anagram Therapeutics, Inc.· Source

• Completed

  A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)

  NCT05878938· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

  NCT05790681· Phase 1· Novo Nordisk A/S· Source

• Terminated

  A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  NCT05600426· Phase 3· Boston Children's Hospital· Source

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Edgewise Therapeutics, Inc.· Source

• Completed

  Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

  NCT05010577· Phase 1/2· BiomX, Inc.· Source

• Completed

  Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

  NCT04965597· Phase 2· Fred Hutchinson Cancer Center· Source

• Completed

  Characterizing Occupational Therapy Intervention for Children With Autism Spectrum Disorders

  NCT05480605· Ohio State University· Source

• Completed

  Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

  NCT05156320· Phase 3· Scholar Rock, Inc.· Source

• Completed

  Defining Endpoints in Becker Muscular Dystrophy

  NCT05257473· Virginia Commonwealth University· Source

• Terminated

  Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

  NCT05305040· Phase 2/3· AlloVir· Source

• Completed

  A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

  NCT04773782· Phase 1/2· Blueprint Medicines Corporation· Source

• Completed

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· Phase 3· Novo Nordisk A/S· Source

• Completed

  Fatty Acid Supplementation in Children With ASD (Study 2)

  NCT04312932· Phase 2· Sarah Keim· Source

• Completed

  A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  NCT05096221· Phase 3· Sarepta Therapeutics, Inc.· Source

• Completed

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Completed

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Completed

  Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

  NCT04717427· University of Illinois Chicago· Source

• Completed

  Ask Suicide-Screening Questions (ASQ) for Youth With Autism Spectrum and Neurodevelopmental Disorders

  NCT04317118· National Institute of Mental Health (NIMH)· Source

• Completed

  Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

  NCT04839354· Phase 3· Claudia R. Morris· Source

• Completed

  Natural History Study of Patients With VCP-related Disease

  NCT04823143· Nationwide Children's Hospital· Source

• Terminated

  A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  NCT04501614· Phase 1/2· Takeda· Source

• Completed

  Fertility Preservation in Male AYA With Cancer

  NCT04268004· Leena Nahata· Source

• Completed

  Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

  NCT04323098· Phase 3· BioMarin Pharmaceutical· Source

• Recruiting

  A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  NCT04462770· Phase 3· Epygenix· Source

• Completed

  Opioid Laws and Pediatric Use

  NCT04543227· Nationwide Children's Hospital· Source

• Completed

  Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older

  NCT04183790· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Completed

  AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.

  NCT04240314· Phase 1/2· Megan Waldrop· Source

• Completed

  Controlled Trial of Gastric Electrical Stimulation in Children

  NCT07474415· Nationwide Children's Hospital· Source

• Completed

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  NCT03847467· Phase 1/2· Children's Hospital Medical Center, Cincinnati· Source

• Terminated

  Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

  NCT03904862· Phase 1/2· Pediatric Brain Tumor Consortium· Source

• Completed

  Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

  NCT03904134· Center for International Blood and Marrow Transplant Research· Source

• Completed

  Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  NCT03709680· Phase 2· Pfizer· Source

• Completed

  Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

  NCT03939637· Phase 3· Baylor College of Medicine· Source

• Completed

  Epilepsy Adherence in Children and Technology (eACT)

  NCT03817229· Children's Hospital Medical Center, Cincinnati· Source

• Completed

  Pediatric Gastroparesis Registry

  NCT03680820· Johns Hopkins Bloomberg School of Public Health· Source

• Completed

  Hydroxyurea Optimization Through Precision Study

  NCT03789591· Phase 3· Lifespan· Source

• Completed

  Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

  NCT03739372· University of California, San Francisco· Source

• Completed

  Body Weight Support Harness System in Spinal Muscular Atrophy

  NCT05715749· Nationwide Children's Hospital· Source

• Completed

  Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

  NCT03526250· Phase 2· National Cancer Institute (NCI)· Source

• Completed

  CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

  NCT03425279· Phase 1/2· BioAtla, Inc.· Source

• Completed

  Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia

  NCT03268421· Children's Hospital Medical Center, Cincinnati· Source

Showing 50 of 110.

Conditions

Diseases this institution publishes on or runs trials for.

• Congenital heart disease69 works · 19 trials
• Cystic fibrosis48 works · 23 trials
• Epilepsy48 works · 6 trials
• Sarcoma46 works · 41 trials
• Childhood cancers45 works · 190 trials
• Duchenne muscular dystrophy38 works · 23 trials
• Sickle cell disease37 works · 11 trials
• Autism21 works · 5 trials
• Neuroblastoma15 works · 32 trials
• Cerebral palsy13 works · 1 trial
• Acute lymphoblastic leukaemia13 works · 30 trials
• Hydrocephalus11 works · 2 trials
• Down syndrome11 works · 6 trials
• Cytomegalovirus infection9 works · 2 trials
• Charcot-Marie-Tooth disease8 works · 4 trials
• Spinal muscular atrophy8 works · 7 trials
• Dermatomyositis and polymyositis (myositis)5 works · 0 trials
• ANCA-associated vasculitis3 works · 0 trials